AU524587B2 - Controlled improvement ofthe 0, release by intact erythrocytes - Google Patents

Controlled improvement ofthe 0, release by intact erythrocytes

Info

Publication number
AU524587B2
AU524587B2 AU39551/78A AU3955178A AU524587B2 AU 524587 B2 AU524587 B2 AU 524587B2 AU 39551/78 A AU39551/78 A AU 39551/78A AU 3955178 A AU3955178 A AU 3955178A AU 524587 B2 AU524587 B2 AU 524587B2
Authority
AU
Australia
Prior art keywords
release
intact erythrocytes
improvement ofthe
controlled improvement
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU39551/78A
Other versions
AU3955178A (en
Inventor
Dr. Klaus Gersonde And Professor Ii. Yves-Claude Nicolau Professor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Studiengesellschaft Kohle gGmbH
Original Assignee
Studiengesellschaft Kohle gGmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772740053 external-priority patent/DE2740053A1/en
Priority claimed from DE19782820603 external-priority patent/DE2820603A1/en
Application filed by Studiengesellschaft Kohle gGmbH filed Critical Studiengesellschaft Kohle gGmbH
Publication of AU3955178A publication Critical patent/AU3955178A/en
Application granted granted Critical
Publication of AU524587B2 publication Critical patent/AU524587B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU39551/78A 1977-09-06 1978-09-05 Controlled improvement ofthe 0, release by intact erythrocytes Expired AU524587B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19772740053 DE2740053A1 (en) 1977-09-06 1977-09-06 USE OF ALLOSTERIC EFFECTORS WITH THE LIPID VESICLES WITH AN IRREVERSIBLE INCORPORATION FOR THE IMPROVED O DEEP 2 DISCHARGE OF THE HAEMOGLOBIN IN ERYTHROCYTES
DEDE2740053 1977-09-06
DE19782820603 DE2820603A1 (en) 1978-05-11 1978-05-11 Erythrocytes modified with allo-steric effector(s) - using lipid vesicles, used for increasing oxygen supply to tissues
DEDE2820603 1978-05-11

Publications (2)

Publication Number Publication Date
AU3955178A AU3955178A (en) 1980-03-13
AU524587B2 true AU524587B2 (en) 1982-09-23

Family

ID=25772674

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39551/78A Expired AU524587B2 (en) 1977-09-06 1978-09-05 Controlled improvement ofthe 0, release by intact erythrocytes

Country Status (12)

Country Link
EP (1) EP0001104B1 (en)
JP (1) JPS6022683B2 (en)
AT (1) AT364086B (en)
AU (1) AU524587B2 (en)
CA (1) CA1130724A (en)
DE (1) DE2860719D1 (en)
DK (1) DK393878A (en)
ES (1) ES473087A1 (en)
IE (1) IE47329B1 (en)
IN (1) IN149223B (en)
IT (1) IT1111675B (en)
YU (1) YU208078A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3144705C2 (en) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Process for the production of a storage-stable, cross-linked hemoglobin preparation with high oxygen transport capacity, as well as the hemoglobin preparation produced by this process
FR2529463B1 (en) * 1982-07-05 1986-01-10 Centre Nat Rech Scient METHOD AND DEVICE FOR THE ENCAPSULATION IN ERYTHROCYTES OF AT LEAST ONE BIOLOGICALLY ACTIVE SUBSTANCE, IN PARTICULAR ALLOSTERIC EFFECTORS OF HEMOGLOBIN AND ERYTHROCYTES OBTAINED THEREBY
NL8403425A (en) * 1984-11-09 1986-06-02 Stichting Gastransport STROMA-FREE HEMOGLOBINE SOLUTION, METHOD FOR PREPARING THE SAME AND USE THEREOF.
JPS6461426A (en) * 1987-08-31 1989-03-08 Terumo Corp Artificial erythrocyte
JPH01305033A (en) * 1988-06-01 1989-12-08 Sanwa Kagaku Kenkyusho Co Ltd Circulation improving agent, circulation improving functional food and tasteful food
JPH01305032A (en) * 1988-06-01 1989-12-08 Sanwa Kagaku Kenkyusho Co Ltd Remedy and preventive for hypofunctional exhaustion and food, drink and tasteful material
US4849416A (en) * 1988-07-25 1989-07-18 Rorer Pharmaceutical Corporation Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
GB9225588D0 (en) 1992-12-08 1993-01-27 Univ Montfort Improving effectiveness of drugs
CN103948545B (en) * 2004-05-03 2017-10-03 益普生生物制药公司 Liposome for drug delivery

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2249552A1 (en) * 1971-10-12 1973-05-30 Inchema S A PROCESS FOR THE INCAPSULATION OF IN PARTICULAR WATER-SOLUBLE COMPOUNDS

Also Published As

Publication number Publication date
IN149223B (en) 1981-10-10
IE781800L (en) 1979-03-06
DE2860719D1 (en) 1981-08-27
ES473087A1 (en) 1979-04-16
EP0001104A2 (en) 1979-03-21
DK393878A (en) 1979-03-07
EP0001104A3 (en) 1979-04-04
IT1111675B (en) 1986-01-13
CA1130724A (en) 1982-08-31
ATA642478A (en) 1981-02-15
YU208078A (en) 1984-02-29
AU3955178A (en) 1980-03-13
AT364086B (en) 1981-09-25
IE47329B1 (en) 1984-02-22
EP0001104B1 (en) 1981-05-20
JPS6022683B2 (en) 1985-06-03
JPS5449314A (en) 1979-04-18
IT7827388A0 (en) 1978-09-06

Similar Documents

Publication Publication Date Title
ZA785026B (en) Controlled improvement of the o2-release by intact erythrocytes
AU521102B2 (en) 2, 6-diaminonebularines
AU4152178A (en) 1,9-dihydroxyoctahydrophenanthrenes
AU513822B2 (en) Controlled release
AU524587B2 (en) Controlled improvement ofthe 0, release by intact erythrocytes
AU519072B2 (en) 1, 1, 1, 2-tetrafluorotha. e
AU2751577A (en) 1, 5-Disubstituted-2-Pyrrolidones
AU520355B2 (en) 2-arylamino-3,5dinitro-benzotrifluorides
AU512404B2 (en) 2, 6-Methano-2H-l-Benzoxocins
AU526584B2 (en) 2,3-dicyanopyrazine derivatives
AU508891B2 (en) 5,6-dihydro-prostacyclin analogs
AU500386B2 (en) 1,2,6-thidiazinones
AU3096577A (en) Substituted 2, 1, 3-benzothiadiazine compounds
AU2546577A (en) 5, 5-trimethylhexanoyl-ferrocene
AU527943B2 (en) 2, 4-diamino-5-benzylpyrimidines
AU515140B2 (en) 2, 4, 7-triamino-pteridine derivatives
AU522993B2 (en) 2',6'-dihydroxy-9-(2,5-dihydroxy-9-(2,5-dihydroxypeny)-octylpheneone as an anti-oxidant
AU518208B2 (en) 2,4-dichlorophenyl-triazolyl-ethan-one and -ol derivatives
AU505434B1 (en) 2, 5 diketogluconic acid
AU517895B2 (en) 1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
AU558695B2 (en) 7(2-thiazoyl,2-oximino acetadimo)-cephalosporins
AU515885B2 (en) SUBSTITUTED 1-PIPERAZINO-TRIAZOLO-THIENO-l, 4-DIAZEPINES
AU518292B2 (en) 1,4-benzoxathin-2-carboxamides
AU505664B2 (en) 2, 1, 3-benzothiadiazoles
AU2242877A (en) 5,6-dehydropenicillins